Goodrich Katherine
SEC insider (Form 3/4/5 filer). CIK 0002044770. Director at Tarsus Pharmaceuticals, Inc. (TARS). 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in IRVINE, CA.
Companies Goodrich Katherine has filed insider reports for
- Tarsus Pharmaceuticals, Inc. (TARS): Director
Goodrich Katherine
CIK: 0002044770
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tarsus Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
3.8K shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
2.4K shares- - Jun 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect3K shares at avg. $62.08$183K - Jun 12, 2026TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect3K shares- - Dec 15, 2025TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect2.2K shares- - Jun 12, 2025TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
3K shares- - Jun 12, 2025TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
4.5K shares- - Nov 13, 2024TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
10K shares- - Nov 13, 2024TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
6.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 3,837 | - | - | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 2,417 | - | - | Direct |
| Jun 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,954 | $62.08 | $183,384 | Direct |
| Jun 12, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 2,954 | - | $0 | Direct |
| Dec 15, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 2,233 | - | $0 | Direct |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 2,954 | - | - | Direct |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 4,540 | - | - | Direct |
| Nov 13, 2024 | TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 10,000 | - | - | Direct |
| Nov 13, 2024 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 6,700 | - | - | Direct |
1-9 of 9 transactions